Rheumatologists' Benefit-Risk Preferences for Biologic Treatments for Rheumatoid Arthritis

被引：0
|
作者：
Hauber, A. Brett [1 ]
Cross, James T. [2 ]
Yocum, David E. [2 ]
Johnson, F. Reed [1 ]
Yang, Jui-Chen [1 ]
Villaneuva, Isidro [2 ]
Katz, Patricia P. [3 ]
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1247
引用
收藏
页码：S487 / S488
页数：2
相关论文
共 50 条
  • [1] Patient Preferences for Biologic Treatments in Rheumatoid Arthritis
    Nafees, Beenish
    Lloyd, Andrew
    Gaich, Carol L.
    Birt, Julie
    Hughes, Rodney A.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S213 - S213
  • [2] BENEFIT-RISK ANALYSIS OF ADALIMUMAB AND ALTERNATIVE TREATMENTS FOR MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS
    Hicks, K. A.
    Earnshaw, S. R.
    Shaw, J. W.
    Cifaldi, M.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A439 - A440
  • [3] Benefit-risk assessment of infliximab in the treatment of rheumatoid arthritis
    Mikuls, TR
    Moreland, LW
    [J]. DRUG SAFETY, 2003, 26 (01) : 23 - 32
  • [4] Benefit-risk tradeoff preferences for chronic hand eczema treatments
    Hauber, A. Brett
    Mohamed, Ateesha F.
    Gonzalez, Juan Marcos
    Fairchild, Angelyn Otteson
    Zelt, Susan C.
    Graff, Ole
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2017, 28 (01) : 40 - 46
  • [5] Benefit-Risk Assessment of Infliximab in the Treatment of Rheumatoid Arthritis
    Ted R. Mikuls
    Larry W. Moreland
    [J]. Drug Safety, 2003, 26 : 23 - 32
  • [6] Biologic treatments for rheumatoid arthritis
    Kotecha, Jalpa B.
    Kiely, Patrick D. W.
    [J]. TRENDS IN UROLOGY & MENS HEALTH, 2019, 10 (05) : 13 - 17
  • [7] Biologic treatments for rheumatoid arthritis
    Berrington, Jenny
    [J]. INTERNATIONAL JOURNAL OF ORTHOPAEDIC AND TRAUMA NURSING, 2006, 10 (03) : 159 - 165
  • [8] Where are we with the benefit-risk ratio of JAK inhibitors in rheumatoid arthritis?
    Avouac, Jerome
    [J]. JOINT BONE SPINE, 2022, 89 (06)
  • [9] A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis
    Jobanputra, P
    Wilson, J
    Douglas, K
    Burls, A
    [J]. RHEUMATOLOGY, 2004, 43 (02) : 206 - 210
  • [10] A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis
    Douglas, KMJ
    Wilson, J
    Buris, A
    Jobanputra, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 414 - 415
12345